HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Wen Cheng Selected Research

ribonucleotide reductase M2

5/2018miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.
10/2011Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ya-Wen Cheng Research Topics

Disease

74Neoplasms (Cancer)
03/2021 - 03/2003
28Lung Neoplasms (Lung Cancer)
01/2017 - 03/2003
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2016 - 09/2003
18Pterygium
04/2014 - 07/2004
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2006
10Carcinogenesis
04/2016 - 09/2003
9Neoplasm Metastasis (Metastasis)
03/2019 - 06/2010
9Adenocarcinoma
09/2013 - 11/2008
7Papillomavirus Infections
01/2017 - 01/2005
6Infections
10/2020 - 08/2005
5Adenocarcinoma of Lung
02/2015 - 12/2010
5Inflammation (Inflammations)
09/2013 - 01/2007
4Hypoxia (Hypoxemia)
10/2016 - 05/2011
4Carcinoma (Carcinomatosis)
01/2013 - 04/2005
3Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2016 - 04/2006
2Ischemic Stroke
12/2020 - 12/2012
2Stroke (Strokes)
12/2020 - 01/2010
2Mouth Neoplasms (Oral Cancer)
08/2017 - 01/2013
2Osteoporosis
06/2016 - 01/2014
2Metabolic Bone Diseases (Osteopenia)
06/2016 - 01/2014
2Colonic Neoplasms (Colon Cancer)
04/2016 - 01/2016
2Squamous Cell Carcinoma of Head and Neck
08/2014 - 01/2012
2Massive Hepatic Necrosis
03/2013 - 01/2013
2Fibrosis (Cirrhosis)
01/2013 - 01/2011
2Chronic Renal Insufficiency
01/2011 - 05/2008
1Actinic Keratosis
01/2022
1COVID-19
10/2020
1Rubella (German Measles)
10/2020
1Experimental Melanoma
03/2019
1Melanoma (Melanoma, Malignant)
03/2019
1Pathologic Processes
03/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2017

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
08/2017 - 09/2003
19Messenger RNA (mRNA)IBA
12/2016 - 09/2003
14DNA (Deoxyribonucleic Acid)IBA
03/2018 - 03/2003
12Oncogene Proteins (Oncogene Protein)IBA
12/2016 - 11/2007
10Biological ProductsIBA
03/2018 - 11/2004
7Biomarkers (Surrogate Marker)IBA
06/2016 - 07/2010
6MicroRNAs (MicroRNA)IBA
12/2016 - 01/2014
6DNA AdductsIBA
04/2016 - 12/2006
4Pharmaceutical PreparationsIBA
03/2019 - 04/2011
4Cisplatin (Platino)FDA LinkGeneric
03/2019 - 11/2010
4MethyltransferasesIBA
08/2017 - 08/2005
4CarcinogensIBA
04/2016 - 01/2005
4Benzo(a)pyreneIBA
04/2016 - 04/2005
4Interleukin-10 (Interleukin 10)IBA
08/2013 - 01/2012
4Codon (Codons)IBA
04/2013 - 02/2005
47,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
01/2013 - 12/2006
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2012 - 01/2007
3Matrix Metalloproteinases (MMPs)IBA
01/2019 - 07/2010
3LuciferasesIBA
03/2018 - 04/2010
3CateninsIBA
01/2017 - 01/2014
3ErbB Receptors (EGF Receptor)IBA
04/2016 - 11/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015 - 05/2008
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2013 - 10/2009
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
11/2012 - 07/2010
3EnzymesIBA
01/2012 - 01/2005
3Indicators and Reagents (Reagents)IBA
10/2011 - 02/2009
3Cyclin-Dependent Kinase Inhibitor p16IBA
09/2009 - 06/2009
2deoxyelephantopinIBA
03/2019 - 03/2013
2SesquiterpenesIBA
03/2019 - 03/2013
2LactonesIBA
03/2019 - 03/2013
2DEET (DET)IBA
03/2019 - 03/2013
2Metalloproteases (Metalloproteinases)IBA
01/2019 - 01/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 01/2014
2ribonucleotide reductase M2IBA
05/2018 - 10/2011
2Estrogen ReceptorsIBA
06/2016 - 12/2005
2TL 1IBA
05/2016 - 08/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015 - 10/2012
2Superoxide DismutaseIBA
02/2015 - 11/2013
2PaxillinIBA
08/2014 - 12/2010
2arginylarginine (Arg-Arg)IBA
04/2013 - 04/2010
2GalactosamineIBA
03/2013 - 01/2013
2SilymarinIBA
03/2013 - 04/2011
2Small Interfering RNA (siRNA)IBA
03/2013 - 07/2010
2Therapeutic UsesIBA
03/2013 - 01/2007
2LipopolysaccharidesIBA
03/2013 - 01/2013
2Interleukin-17 (Interleukin 17)IBA
01/2013 - 10/2010
2CreatinineIBA
01/2013 - 01/2011
2Interleukin-6 (Interleukin 6)IBA
11/2012 - 08/2008
2InterleukinsIBA
10/2010 - 08/2008
2Monoclonal AntibodiesIBA
02/2010 - 08/2008
2ParaffinIBA
06/2009 - 05/2006
2AminesIBA
07/2007 - 06/2005
2Caspase 3 (Caspase-3)IBA
04/2007 - 11/2004
13-ingenyl angelateIBA
01/2022
1S100 Calcium-Binding Protein A4IBA
01/2022
1Epidermal Growth Factor (EGF)IBA
03/2021
1Antiviral Agents (Antivirals)IBA
10/2020
1FurinIBA
10/2020
1Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA
10/2020
1Immunoglobulin G (IgG)IBA
10/2020
1MetallothioneinIBA
08/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
15-Methylcytosine (5 Methylcytosine)IBA
03/2018
1Arginine (L-Arginine)FDA Link
08/2017
1periodate-oxidized adenosineIBA
08/2017

Therapy/Procedure

8Therapeutics
10/2015 - 04/2009
7Drug Therapy (Chemotherapy)
12/2016 - 07/2010
1Ischemic Postconditioning
12/2020